Abstract
Pharmacology and therapeutics have traditionally focused on altering the activity of specific proteins that play an important physiological role either to counteract disease processes or to achieve changes in physiology that are of benefit to the patient. The explossion in our understanding of gene expression programs opens up new horizons for pharmacological intervention. Key processes reversibly controlling genetic programs are attractive drug targets. DNA methylation is a fundamental feature of genomes and the control of their function and is therefore a candidate for pharmacological manipulation that might have important therapeutic advantage. This review argues that DNA methylation plays an important role in the control of genomic processes, suggests how the DNA methylation machinery is involved in cancer, identifies the enzymatic processes that are a target for drug intervention, proposes potential therapeutic utilities for agents that manipulate the DNA methylation machinery and discusses nov el drugs that target the DNA methylation machinery
Keywords: DNA Methylation, DNA Demethylases, CIS, Trans, DNA replication, Oncogenic signals, Cell arrest, Tumor suppressor Genes, Normal replication, Cellular Transformation
Current Drug Targets
Title: The DNA Methylation Machinery as a Therapeutic Target
Volume: 1 Issue: 1
Author(s): Moshe Szyf
Affiliation:
Keywords: DNA Methylation, DNA Demethylases, CIS, Trans, DNA replication, Oncogenic signals, Cell arrest, Tumor suppressor Genes, Normal replication, Cellular Transformation
Abstract: Pharmacology and therapeutics have traditionally focused on altering the activity of specific proteins that play an important physiological role either to counteract disease processes or to achieve changes in physiology that are of benefit to the patient. The explossion in our understanding of gene expression programs opens up new horizons for pharmacological intervention. Key processes reversibly controlling genetic programs are attractive drug targets. DNA methylation is a fundamental feature of genomes and the control of their function and is therefore a candidate for pharmacological manipulation that might have important therapeutic advantage. This review argues that DNA methylation plays an important role in the control of genomic processes, suggests how the DNA methylation machinery is involved in cancer, identifies the enzymatic processes that are a target for drug intervention, proposes potential therapeutic utilities for agents that manipulate the DNA methylation machinery and discusses nov el drugs that target the DNA methylation machinery
Export Options
About this article
Cite this article as:
Szyf Moshe, The DNA Methylation Machinery as a Therapeutic Target, Current Drug Targets 2000; 1 (1) . https://dx.doi.org/10.2174/1389450003349362
DOI https://dx.doi.org/10.2174/1389450003349362 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Therapeutic Application of the Association of Vitamins C and K3 in Cancer Treatment
Current Medicinal Chemistry The Update of NGAL in Acute Kidney Injury
Current Protein & Peptide Science Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?
Current Drug Metabolism Recent Patents in Glycan-Based Cancer Biomarkers and Discovery Technologies
Recent Patents on Biomarkers The Use of Technetium-99m Radiolabeled Human Antimicrobial Peptides for Infection Specific Imaging
Mini-Reviews in Medicinal Chemistry Management of Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Current Immunology Reviews (Discontinued) Recent Advances in Azo Dye Degrading Enzyme Research
Current Protein & Peptide Science Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
Current Radiopharmaceuticals Therapeutic Antibodies
Current Molecular Medicine Drug Tissue Distribution: Study Methods and Therapeutic Implications
Current Pharmaceutical Design Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer
Current Cancer Drug Targets Protein Misfolding and Misprocessing in Complex Disease
Protein & Peptide Letters Adenovirus-based Immunotherapy for Prostate Cancer
Current Cancer Therapy Reviews The Synthesis of Chalcones as Anticancer Prodrugs and their Bioactivation in CYP1 Expressing Breast Cancer Cells
Medicinal Chemistry Hepatocellular Carcinoma: Important Biomarkers and their Significance in Molecular Diagnostics and Therapy
Current Medicinal Chemistry Quality Survival with Advanced Cervical Cancer
Current Women`s Health Reviews The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Current Signal Transduction Therapy Clinical Applications of Mesenchymal Stem Cells in Laryngotracheal Reconstruction
Current Stem Cell Research & Therapy Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology